Literature DB >> 27154981

Energy metabolism and inflammation in brain aging and Alzheimer's disease.

Fei Yin1, Harsh Sancheti2, Ishan Patil2, Enrique Cadenas2.   

Abstract

The high energy demand of the brain renders it sensitive to changes in energy fuel supply and mitochondrial function. Deficits in glucose availability and mitochondrial function are well-known hallmarks of brain aging and are particularly accentuated in neurodegenerative disorders such as Alzheimer's disease. As important cellular sources of H2O2, mitochondrial dysfunction is usually associated with altered redox status. Bioenergetic deficits and chronic oxidative stress are both major contributors to cognitive decline associated with brain aging and Alzheimer's disease. Neuroinflammatory changes, including microglial activation and production of inflammatory cytokines, are observed in neurodegenerative diseases and normal aging. The bioenergetic hypothesis advocates for sequential events from metabolic deficits to propagation of neuronal dysfunction, to aging, and to neurodegeneration, while the inflammatory hypothesis supports microglia activation as the driving force for neuroinflammation. Nevertheless, growing evidence suggests that these diverse mechanisms have redox dysregulation as a common denominator and connector. An independent view of the mechanisms underlying brain aging and neurodegeneration is being replaced by one that entails multiple mechanisms coordinating and interacting with each other. This review focuses on the alterations in energy metabolism and inflammatory responses and their connection via redox regulation in normal brain aging and Alzheimer's disease. Interaction of these systems is reviewed based on basic research and clinical studies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Brain aging; Glucose metabolism; Inflammation; Mitochondria; Redox control

Mesh:

Substances:

Year:  2016        PMID: 27154981      PMCID: PMC5094909          DOI: 10.1016/j.freeradbiomed.2016.04.200

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  244 in total

Review 1.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

Review 2.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

3.  Growth hormone alters the glutathione S-transferase and mitochondrial thioredoxin systems in long-living Ames dwarf mice.

Authors:  Lalida Rojanathammanee; Sharlene Rakoczy; Holly M Brown-Borg
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-27       Impact factor: 6.053

4.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging.

Authors:  Yun-Hee Youm; Ryan W Grant; Laura R McCabe; Diana C Albarado; Kim Yen Nguyen; Anthony Ravussin; Paul Pistell; Susan Newman; Renee Carter; Amanda Laque; Heike Münzberg; Clifford J Rosen; Donald K Ingram; J Michael Salbaum; Vishwa Deep Dixit
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

5.  Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

Authors:  Bruno P Imbimbo; Vincenzo Solfrizzi; Francesco Panza
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

6.  Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

Authors:  I A Simpson; K R Chundu; T Davies-Hill; W G Honer; P Davies
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

7.  Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury-induced cytokine response after excitotoxic damage.

Authors:  O Campuzano; M M Castillo-Ruiz; L Acarin; B Castellano; B Gonzalez
Journal:  J Neurosci Res       Date:  2009-08-15       Impact factor: 4.164

Review 8.  Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.

Authors:  S G Rhee; W Jeong; T-S Chang; H A Woo
Journal:  Kidney Int Suppl       Date:  2007-08       Impact factor: 10.545

9.  Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone.

Authors:  S D Harr; N A Simonian; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  1995-01       Impact factor: 3.685

10.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

View more
  133 in total

1.  Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia.

Authors:  Mary K Swinton; Aliyah Carson; Francesca Telese; Ana B Sanchez; Benchawanna Soontornniyomkij; Leila Rad; Isabella Batki; Brandi Quintanilla; Josué Pérez-Santiago; Cristian L Achim; Scott Letendre; Ronald J Ellis; Igor Grant; Anne N Murphy; Jerel Adam Fields
Journal:  Neurobiol Dis       Date:  2019-06-22       Impact factor: 5.996

2.  miR-146a Dysregulates Energy Metabolism During Neuroinflammation.

Authors:  Sujung Jun Kim; Ashley E Russell; Wei Wang; Darren E Gemoets; Saumyendra N Sarkar; James W Simpkins; Candice M Brown
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-24       Impact factor: 4.147

3.  Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.

Authors:  Lin Wang; Bing-Jin Liu; Yun Cao; Wei-Qi Xu; Dong-Sheng Sun; Meng-Zhu Li; Fang-Xiao Shi; Man Li; Qing Tian; Jian-Zhi Wang; Xin-Wen Zhou
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

4.  Geniposide Increases Unfolded Protein Response-Mediating HRD1 Expression to Accelerate APP Degradation in Primary Cortical Neurons.

Authors:  Huaqing Cui; Mengsheng Deng; Yonglan Zhang; Fei Yin; Jianhui Liu
Journal:  Neurochem Res       Date:  2018-02-09       Impact factor: 3.996

5.  Loss of NRF2 leads to impaired mitochondrial function, decreased synaptic density and exacerbated age-related cognitive deficits.

Authors:  Jonathan A Zweig; Maya Caruso; Mikah S Brandes; Nora E Gray
Journal:  Exp Gerontol       Date:  2019-12-13       Impact factor: 4.032

Review 6.  Socially Housed Female Macaques: a Translational Model for the Interaction of Chronic Stress and Estrogen in Aging.

Authors:  Donna Toufexis; S Bradley King; Vasiliki Michopoulos
Journal:  Curr Psychiatry Rep       Date:  2017-09-14       Impact factor: 5.285

7.  PGC-1α-Mediated Mitochondrial Biogenesis is Involved in Cannabinoid Receptor 2 Agonist AM1241-Induced Microglial Phenotype Amelioration.

Authors:  Lei Ma; Wen Niu; Jianrui Lv; Ji Jia; Miaozhang Zhu; Shuai Yang
Journal:  Cell Mol Neurobiol       Date:  2018-10-12       Impact factor: 5.046

Review 8.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

9.  The Effects of Normal Aging on Regional Accumulation of Hyaluronan and Chondroitin Sulfate Proteoglycans in the Mouse Brain.

Authors:  May J Reed; Mamatha Damodarasamy; Jasmine L Pathan; Michelle A Erickson; William A Banks; Robert B Vernon
Journal:  J Histochem Cytochem       Date:  2018-05-21       Impact factor: 2.479

Review 10.  Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility.

Authors:  Jonathan M Borkum
Journal:  Neurochem Res       Date:  2021-04-30       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.